The Twisted Hilbert Space Ideals Cabello Sánchez, Félix; García, Ricardo
Integral equations and operator theory,
06/2022, Volume:
94, Issue:
2
Journal Article
Peer reviewed
Open access
We study those operators on a Hilbert space that can be lifted or extended to any twisted Hilbert space. We prove that these form an ideal of operators which contains all the Schatten classes. We ...characterize those multiplication operators on
ℓ
p
that are liftable/extensible through centralizers.
Donor derived regulatory T lymphocytes and the JAK1/2 kinase inhibitor ruxolitinib are currently being evaluated as therapeutic options in the treatment of chronic graft versus host disease (cGvHD). ...In this work, we aimed to determine if the combined use of both agents can exert a synergistic effect in the treatment of GvHD. For this purpose, we studied the effect of this combination both in vitro and in a GvHD mouse model. Our results show that ruxolitinib favors the ratio of thymic regulatory T cells to conventional T cells in culture, without affecting the suppressive capacity of these Treg. The combination of ruxolitinib with Treg showed a higher efficacy as compared to each single treatment alone in our GvHD mouse model in terms of GvHD incidence, severity and survival without hampering graft versus leukemia effect. This beneficial effect correlated with the detection in the bone marrow of recipient mice of the infused donor allogeneic Treg after the adoptive transfer.
Zero, one, or three? The role of Au0, AuI, and AuIII cations in the heterogeneous gold catalyst Au/CeO2 was investigated with the copper‐free Sonogashira cross‐coupling reaction of iodobenzene and ...phenyl acetylene (see picture). Reactions carried out under both heterogeneous and homogeneous conditions using distinct Au0, AuI, and AuIII species reveal that AuI is the active species for the cross‐coupling reaction.
Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing.
This updated ...cross-sectional study used the same methods as the International study of Asthma and Allergies in Childhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders.
Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27, in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries.
Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma.
International Union Against Tuberculosis and Lung Disease, Boehringer Ingelheim New Zealand, AstraZeneca Educational Grant, National Institute for Health Research, UK Medical Research Council, European Research Council, and Instituto de Salud Carlos III.
Tthe present work studied the cationic substitution of Y3+ by Bi3+ on the crystal structure of orthorhombic YFeO3 and its effect over magnetic, dielectric and electric properties of multiferroic ...yttrium orthoferrite. Stoichiometric mixtures of Y2O3, Fe2O3 and Bi2O3 were mixed and milled for 5 h using a ball to powder weight ratio of 10:1 by high-energy ball milling. The obtained powders were pressed at 1500 MPa and sintered at 700 °C for 2 h. The test samples were characterized at room temperature by X-ray diffraction (XRD), vibrating sample magnetometer (VSM), scanning electron microscope (SEM), energy dispersive X-ray spectroscopy (EDS) and impedance spectroscopy (IS). The X-ray diffraction patterns disclosed a maximum solubility of 30 % mol. of Bi3+ into the orthorhombic YFeO3. For higher concentrations, a transformation from orthorhombic to garnet structure was produced, obtaining partially Y3Fe5O12 phase. The substitution of Bi3+ in Y3+ sites promoted a distortion into the orthorhombic structure and modified Fe-O-Fe angles and octahedral tilt. In addition, it promoted a ferromagnetic (FM) order, which was attributed to both the crystal distortion and Dzyaloshinskii-Moriya interaction. For doped samples, an increase in real permittivity values was observed, and reduced with the increase of frequency. This in good agreement with the Maxwell-Wagner effect.
Three novel polyimides have been successfully synthesized from 3,8-diphenylpyrene-1,2,6,7-tetracarboxylic dianhydride (DPPD), and three commercial diamines by solution polycondensation. All polymers ...exhibited high molecular weight, high thermal stability and high rigidity (no glass transition was detected up to 400°C) and free volume. The new polymers have been tested as gas separation membranes, showing very good combination of permeability and selectivity, especially in the case of the polymer derived from trimethyl-m-phenylenediamine (TMPD), which overpassed the 1991 Robeson upper bound for the gas pairs O2/N2 and CO2/CH4 and was near the 2008 upper bound for CO2/N2.
Display omitted
•A planar and rigid dianhydride has been used to prepare gas separation polyimides.•PCO2/PHe and PCH4/PN2 ratios are reversed compared to glassy polymers (as in PIMs).•Very high permeability has been attained by combining with ortho-substituted diamines.•Meta-substitution in diamine significantly improves permeability.•New polyimides show excellent combination of permeability and selectivity for CO2/N2.
Chemokine stromal cell–derived factor-1 (SDF-1) is expressed by bone marrow (BM) stromal cells and plays key roles in BM cell migration. Modulation of its expression could affect the migratory ...capacity of cells trafficking the BM, such as hematopoietic progenitor and leukemic cells. Transforming growth factor-β1 (TGF-β1) is present in the BM environment and constitutes a pivotal molecule controlling BM cell proliferation and differentiation. We used the BM stromal cell line MS-5 as a model to investigate whether SDF-1 expression constitutes a target for TGF-β1 regulation and its functional consequences. We show here that TGF-β1 down-regulates SDF-1 expression, both at the mRNA level, involving a decrease in transcriptional efficiency, and at the protein level, as detected in lysates and supernatants from MS-5 cells. Reduction of SDF-1 in supernatants from TGF-β1–treated MS-5 cells correlated with decreased, SDF-1–dependent, chemotactic, and transendothelial migratory responses of the BM model cell lines NCI-H929 and Mo7e compared with their responses to supernatants from untreated MS-5 cells. In addition, supernatants from TGF-β1–exposed MS-5 cells had substantially lower efficiency in promoting integrin α4β1–mediated adhesion of NCI-H929 and Mo7e cells to soluble vascular cell adhesion molecule-1 (sVCAM-1) and CS-1/fibronectin than their untreated counterparts. Moreover, human cord blood CD34+ hematopoietic progenitor cells displayed SDF-1–dependent reduced responses in chemotaxis, transendothelial migration, and up-regulation of adhesion to sVCAM-1 when supernatants from TGF-β1–treated MS-5 cells were used compared with supernatants from untreated cells. These data indicate that TGF-β1–controlled reduction in SDF-1 expression influences BM cell migration and adhesion, which could affect the motility of cells trafficking the bone marrow.
Inclusion body myositis (IBM) is an acquired inflammatory myopathy affecting proximal and distal muscles that leads to weakness in patients over 50. It is diagnosed based on clinical and histological ...findings in muscle related to inflammation, degeneration, and mitochondria. In relation to IBM, a shortage of validated disease models and a lack of biomarkers and effective treatments constitute an unmet medical need. To overcome these hurdles, we performed an omics analysis of multiple samples from IBM patients (saliva, fibroblasts, urine, plasma, and muscle) to gain insight into the pathophysiology of IBM. Degeneration was evident due to the presence of amyloid β peptide 1–42 (Aβ1–42) in the saliva of the analyzed IBM patients. The presence of metabolic disarrangements in IBM was indicated by an imbalanced organic acid profile in fibroblasts and urine. Specifically, abnormal levels of L-pyroglutamic and orotic acid were supported by the abnormal expression of related metabolites in plasma and urine (glutathione and pyrimidines) and the aberrant expression of upstream gene regulators (L2HGDH, IDH2, OPLAH, and ASL) in muscle. Combined levels of L-pyroglutamic and orotic acid displayed an outstanding biomarker signature in urine with 100% sensitivity and specificity. The confirmation of systemic metabolic disarrangements in IBM and the identification of novel biomarkers reported herein unveil novel insights that require validation in larger cohorts.
Dioscorea composita is a plant with historical recognition for the production of secondary metabolites of pharmaceutical importance, including diosgenin, and with great nutritional and ethnobotanical ...value in its center of origin (México and Central America). Furthermore, it is considered a promising therapeutic agent against cancer. Currently, México is one of the two most important countries producing this yam; however, climate change is altering the environmental conditions of its natural habits, threatening its preservation and productivity. This is why this research was focused on characterizing the eco-geography of D. composita and predicting its potential geographic distribution under climate change scenarios in México-Central America. A collection of 408 geo-referenced accessions was used to determine its climatic adaptation, ecological descriptors, and the current and future potential geographic distribution, which was modeled with the MaxEnt model through the Kuenm R-package. For future climate scenarios, an ensemble of the GCMs HadGEM-ES and CCSM4 was used. Results showed that D. composita adapts to warm and humid and very humid agro-climates and, the most contributing variables for its presence are annual and seasonal moisture availability indices, the seasonal photoperiod, annual thermal range, and Bio14 and Bio11. The current potential distribution (692,123 km2) of D. composita might decrease by the year 2050 RCP4.5 (365,680 km2) and might increase by 2050 under the scenario RCP8.5 (763,589 km2), showing this plant could be a good crop option for this climate change scenario. The findings obtained provide valuable information that will allow for the effective utilization of this plant, both in terms of developing new pharmaceutical products and implementing appropriate conservation strategies.
A large retrospective multicentre study was conducted in Spain to evaluate the efficiency of the new European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) criteria for ...the diagnosis of coeliac disease (CD).
The study protocol was approved by the ethics committee of Hospital Universitari i Politècnic La Fe (Valencia, Spain). The present study included 2177 children (ages 0.6-15.9 years) with small bowel biopsy (SBB) performed for diagnostic purposes (from 2000 to 2009) and with a minimum 2-year follow-up after biopsy.
CD was diagnosed in 2126 patients (97.5%) and excluded in 51 (2.5%). Tissue transglutaminase antibodies (TG2A), anti-endomysial antibodies (EMA), and human leukocyte antigen (HLA) were reported in 751 patients, 640 symptomatic and 111 asymptomatic. TG2A levels >10 times the upper limit of normal, plus positive EMA and HLA DQ2 and/or DQ8 haplotypes, were found in 336 symptomatic patients, all of them with final diagnosis of CD. In 65 of 69 asymptomatic patients, 65 had confirmed CD and 4 did not have CD. According to the 2012 ESPGHAN guidelines, SBB may have been omitted in 52% of the symptomatic patients with CD with serologic and HLA available data. Gluten challenge was performed in 158 children, 75 of them <2 years at first biopsy. Only 1 patient in whom according to the new proposed diagnostic criteria gluten challenge would not have been mandatory did not relapse.
Our results support the new ESPGHAN 2012 guidelines for diagnosis of CD can be safely used without the risk of overdiagnosis. A prospective multicentre study is needed to confirm our results.
PDF
